Medicine

Projects

Projects per year 1975 1989 2002 2005 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2025

• 25 Not started
• 128 Active
• 802 Finished

Projects per year

Search results

• ALTERED EPINEPHRINE RESPONSES IN DIABETES

  Shamoon, H.

  National Institute of Diabetes and Digestive and Kidney Diseases

  1/1/90 → 1/1/90

  Project: Research project

  • Epinephrine 100%
  • Glucose 58%
  • Hypoglycemia 49%
  • Glucagon 48%
  • Type 1 Diabetes Mellitus 41%

• A Major Nutritional Effect on Intestinal Stem Cells and Tumors

  Augenlicht, L. H.

  National Cancer Institute

  7/17/18 → 5/31/22

  Project: Research project

  • stem cells 100%
  • neoplasms 71%
  • carcinogenesis 44%
  • homeostasis 21%
  • cells 20%

• A Major Nutritional Effect on Intestinal Stem Cells and Tumors

  Augenlicht, L. H.

  7/17/18 → 5/31/21

  Project: Research project

  • stem cells 100%
  • neoplasms 46%
  • carcinogenesis 41%
  • homeostasis 19%
  • cells 19%

• A mobile intervention to promote cessation in HIV-infected smokers

  Abroms, L. & Shuter, J.

  NATIONAL INSTITUTE ON DRUG ABUSE

  5/15/14 → 4/30/19

  Project: Research project

  • HIV Infections 100%
  • Smokers 89%
  • Smartphone 68%
  • HIV 68%
  • Smoke 67%

• A mobile intervention to promote cessation in HIV-infected smokers

  Abroms, L., Shuter, J., Rose, S. A., Rose, S. A. & Shuter, J.

  5/15/14 → 4/30/19

  Project: Research project

  • HIV Infections 100%
  • Smartphone 68%
  • Smoke 67%
  • Smokers 59%
  • Tobacco 53%

• Analysis of minK &MiRP Regulation of Cardiac K Channels

  McDonald, T. V.

  National Heart, Lung, and Blood Institute

  12/15/03 → 11/30/08

  Project: Research project

  • Mink 100%
  • Cardiac Arrhythmias 28%
  • Voltage-Gated Potassium Channels 22%
  • Long QT Syndrome 22%
  • Proteins 18%

• Analysis of novel in vivo derived Plasmodium falciparum transcriptional profiles

  Daily, J. P. & Rose, S. A.

  7/15/08 → 6/30/14

  Project: Research project

  • parasites 100%
  • Biological Sciences 63%
  • malaria 50%
  • Plasmodium falciparum 46%
  • clinical trials 31%

• Analysis of novel in vivo derived Plasmodium falciparum transcriptional profiles

  Daily, J. P.

  National Institute of Allergy and Infectious Diseases

  7/15/08 → 6/30/14

  Project: Research project

  • Plasmodium falciparum 100%
  • parasites 63%
  • Biological Sciences 40%
  • malaria 31%
  • clinical trials 19%

• Analyzing Genes for Autoimmune Thyroiditis and Diabetes: Translation to Therapy

  Tomer, Y.

  National Institute of Diabetes and Digestive and Kidney Diseases

  3/1/05 → 3/31/22

  Project: Research project

  • Autoimmune Thyroiditis 100%
  • Type 1 Diabetes Mellitus 70%
  • thyroid diseases 68%
  • Thyroid Diseases 66%
  • insulin-dependent diabetes mellitus 59%

• A new molecular pathway for diabetic cardiomyopathy

  Kitsis, R. N. & Yoshioka, J. U. N.

  1/15/16 → 12/31/20

  Project: Research project

  • Thioredoxins 100%
  • Diabetic Cardiomyopathies 46%
  • bcl-2-Associated X Protein 41%
  • Hyperglycemia 22%
  • Systolic Heart Failure 16%

• A new molecular pathway for diabetic cardiomyopathy

  Kitsis, R. N. & YOSHIOKA, J.

  National Heart, Lung, and Blood Institute

  5/5/16 → 12/31/20

  Project: Research project

  • Thioredoxins 100%
  • Diabetic Cardiomyopathies 98%
  • bcl-2-Associated X Protein 41%
  • Hyperglycemia 22%
  • Systolic Heart Failure 16%

• AN INVESTIGATION OF THE NATURAL HISTORY OF HIV IN WOMEN

  Anastos, K., Weiser, B., Weiser, B., Sharma, A., Rose, S. A. & Rose, S. A.

  1/1/01 → 12/31/19

  Project: Research project

  • HIV 100%
  • Primary Health Care 65%
  • Natural History 62%
  • Disease Progression 33%
  • Lebanon 28%

• ANTHRACYCLINES WITH HIGH AFFINITY FOR LIPID MEMBRANES

  Perez-Soler, R.

  1/1/91 → 12/31/99

  Project: Research project

  • Anthracycline 100%
  • Doxorubicin 77%
  • Anthracycline Antibiotic Agent 75%
  • Resistance 46%
  • Liposome 45%

• Anti-angiogenic actions of taxotere

  Schwartz, E. L. & Rose, S. A.

  9/29/03 → 6/30/09

  Project: Research project

  • Docetaxel 100%
  • Microtubule-Organizing Center 37%
  • Microtubules 31%
  • Endothelial Cells 28%
  • Cell Movement 26%

• Anti-angiogenic actions of taxotere

  Schwartz, E. L.

  National Cancer Institute

  9/29/03 → 6/30/09

  Project: Research project

  • Docetaxel 100%
  • Microtubule-Organizing Center 40%
  • Microtubules 33%
  • Endothelial Cells 30%
  • Cell Movement 27%

• Antibodies, B cells and resistance to human cryptococcosis

  Pirofski, L.

  National Institute of Allergy and Infectious Diseases

  7/25/19 → 6/30/22

  Project: Research project

  • Cryptococcal Meningitis 100%
  • Cryptococcosis 70%
  • B-Lymphocytes 44%
  • Immune Reconstitution Inflammatory Syndrome 41%
  • Antibodies 32%

• Antibodies, B cells and resistance to human cryptococcosis

  Pirofski, L.

  7/25/19 → 6/30/22

  Project: Research project

  • Cryptococcal Meningitis 100%
  • Immune Reconstitution Inflammatory Syndrome 41%
  • Glucans 31%
  • HIV 26%
  • B-Lymphocytes 14%

• Antibodies associated with protection against tuberculosis in nonhuman primates

  Achkar, J. M.

  8/18/17 → 7/31/20

  Project: Research project

  • Tuberculosis 100%
  • Infections 30%
  • Primates 19%
  • Antigens 18%
  • Macaca 15%

• Antibodies associated with protection against tuberculosis in nonhuman primates

  Achkar, J. M.

  National Institute of Allergy and Infectious Diseases

  8/18/17 → 7/31/20

  Project: Research project

  • Tuberculosis 100%
  • Primates 89%
  • Antibodies 54%
  • Infections 32%
  • Antigens 19%

• ANTIBODY ACTION MECHANISM AGAINST CRYPTOCOCCUS NEOFORMAN

  Feldmesser, M.

  National Institutes of Health

  8/1/96 → 7/31/01

  Project: Research project

  • Cryptococcus neoformans 100%
  • Antibodies 43%
  • Lung 36%
  • Infections 21%
  • Fungi 20%

• Antibody differentially alters Histoplasma extracellular vesicles

  Nosanchuk, J. D.

  National Institute of Allergy and Infectious Diseases

  2/15/16 → 1/31/19

  Project: Research project

  • Histoplasma 100%
  • Extracellular Vesicles 67%
  • Antibodies 33%
  • Fungi 30%
  • Monoclonal Antibodies 16%

• Antibody differentially alters Histoplasma extracellular vesicles

  Nosanchuk, J. D.

  2/15/16 → 1/31/19

  Project: Research project

  • Histoplasma 100%
  • Extracellular Vesicles 35%
  • Fungi 27%
  • Antibodies 22%
  • Monoclonal Antibodies 14%

• Antibody immunity to serotype 3 Streptococcus pneumoniae

  Pirofski, L. & Rose, S. A.

  9/10/13 → 8/31/16

  Project: Research project

  • Serogroup 100%
  • Polysaccharides 34%
  • type III pneumococcal polysaccharide 22%
  • Immunity 19%
  • Streptococcus pneumoniae 18%

• Antibody immunity to serotype 3 Streptococcus pneumoniae

  Pirofski, L.

  National Institute of Allergy and Infectious Diseases

  9/10/13 → 8/31/16

  Project: Research project

  • Serogroup 100%
  • Streptococcus pneumoniae 80%
  • Immunity 66%
  • Antibodies 46%
  • Polysaccharides 35%

• Antibody Protection in Histoplamosis

  Nosanchuk, J. D. & Rose, S. A.

  12/1/04 → 11/30/10

  Project: Research project

  • Histoplasma 100%
  • Fungi 31%
  • Monoclonal Antibodies 26%
  • Histones 24%
  • Antibodies 24%

• Antibody Protection in Histoplamosis

  Nosanchuk, J. D.

  National Institute of Allergy and Infectious Diseases

  12/1/04 → 11/30/10

  Project: Research project

  • Histoplasma 100%
  • Antibodies 37%
  • Fungi 31%
  • Monoclonal Antibodies 26%
  • Histones 24%

• ANTIBODY STRUCTURE IN ADENOVIRUS INFECTION

  Pirofski, L. & Hoshino, Y.

  1/1/90 → 8/31/90

  Project: Research project

• Antibody therapy for pneumococcal disease

  Pirofski, L.

  National Institute of Allergy and Infectious Diseases

  11/10/16 → 10/31/21

  Project: Research project

  • Pneumococcal Infections 100%
  • Serogroup 80%
  • Pneumonia 55%
  • Antibodies 46%
  • Monoclonal Antibodies 43%

• Antibody therapy for pneumococcal disease

  Pirofski, L.

  11/10/16 → 10/31/21

  Project: Research project

  • Serogroup 100%
  • Pneumonia 68%
  • Pneumococcal Infections 59%
  • Monoclonal Antibodies 53%
  • Antibodies 40%

• A Pilot Study of Positively Smoke Free on the Web (PSFW) for HIV-infected Smokers

  Shuter, J. & Stanton, C.

  National Cancer Institute

  9/27/11 → 8/31/14

  Project: Research project

  • Smoke 100%
  • Smokers 97%
  • HIV 92%
  • Tobacco 31%
  • Tobacco Use Cessation 20%

• A Pilot Study of Positively Smoke Free on the Web (PSFW) for HIV-infected Smokers

  Shuter, J., Stanton, C., Rose, S. A. & Rose, S. A.

  9/27/11 → 8/31/14

  Project: Research project

  • HIV 100%
  • Smokers 61%
  • Smoke 34%
  • Tobacco 34%
  • Internet 23%

• Apolipoprotein A5 and Gallstone Formation

  Wang, D. Q. H.

  National Institute of Diabetes and Digestive and Kidney Diseases

  7/20/18 → 4/30/22

  Project: Research project

  • cholelithiasis 100%
  • apolipoproteins 97%
  • bile 59%
  • cholesterol 31%
  • liver 27%

• Apolipoprotein A5 and Gallstone Formation

  Wang, D. Q. H.

  7/20/18 → 4/30/22

  Project: Research project

  • apolipoproteins 100%
  • bile 58%
  • cholelithiasis 55%
  • cholesterol 30%
  • liver 26%

• ARC, a Master Repressor of Apoptosis in Striated Muscle

  Kitsis, R. N.

  National Heart, Lung, and Blood Institute

  9/30/98 → 6/30/08

  Project: Research project

  • AIDS-Related Complex 100%
  • Apoptosis 85%
  • Striated Muscle 73%
  • Caspases 72%
  • Cardiac Myocytes 72%

• Aspergillosis: Engineering Antibody for Diagnosis

  Feldmesser, M.

  National Institutes of Health

  6/15/05 → 5/31/08

  Project: Research project

  • galactomannan 100%
  • Aspergillosis 85%
  • Aspergillus fumigatus 66%
  • Antibodies 50%
  • Monoclonal Antibodies 29%

• Aspergillosis: Engineering Antibody for Diagnosis

  Feldmesser, M.

  National Institute of Allergy and Infectious Diseases

  6/15/05 → 5/31/08

  Project: Research project

  • galactomannan 100%
  • Aspergillosis 85%
  • Aspergillus fumigatus 66%
  • Antibodies 50%
  • Monoclonal Antibodies 29%

• Assay development for high throughput screening of selectin ligand antagonists

  Frenette, P. S.

  9/15/06 → 8/31/10

  Project: Research project

  • Fucosyltransferases 100%
  • Selectins 59%
  • High-Throughput Screening Assays 39%
  • Leukocytes 36%
  • Ligands 26%

• Assay development for high throughput screening of selectin ligand antagonists

  Frenette, P. S. & Rose, S. A.

  National Institute of Allergy and Infectious Diseases

  9/15/06 → 8/31/10

  Project: Research project

  • Fucosyltransferases 100%
  • High-Throughput Screening Assays 78%
  • Selectins 77%
  • Ligands 40%
  • Leukocytes 36%

• Assessing genome sequence integrity in normal human cells

  Spivack, S. D., Vijg, J. & Vijg, J.

  8/15/18 → 5/31/22

  Project: Research project

  • Mutation 100%
  • Genome 74%
  • Smoke 52%
  • Tobacco 52%
  • DNA 45%

• Assessing genome sequence integrity in normal human cells

  Spivack, S. D. & Vijg, J.

  National Institute of Environmental Health Sciences

  8/15/18 → 5/31/22

  Project: Research project

  • Genome 100%
  • Mutation 82%
  • DNA 39%
  • Smoke 39%
  • Tobacco 39%

• Astrocytic Target Mechanisms in Obesity

  Yang, Y.

  National Institute of Diabetes and Digestive and Kidney Diseases

  8/1/17 → 7/31/21

  Project: Research project

  • Obesity 100%
  • Astrocytes 94%
  • Adenosine 63%
  • Agouti-Related Protein 61%
  • Diet 35%

• Astrocytic Target Mechanisms in Obesity

  Yang, Y.

  8/1/17 → 7/31/21

  Project: Research project

  • Obesity 100%
  • Astrocytes 87%
  • Adenosine 58%
  • Agouti-Related Protein 57%
  • Diet 32%

• A Systems Biology Approach to the Model Apicomplexan Toxoplasma gondii

  Kim, K. & Sullivan, W.

  National Institute of Allergy and Infectious Diseases

  9/30/10 → 9/29/13

  Project: Research project

  • Toxoplasma gondii 100%
  • systems biology 80%
  • parasites 69%
  • proteomics 51%
  • pathogens 51%

• A Systems Biology Approach to the Model Apicomplexan Toxoplasma gondii

  Kim, K. & Sullivan, W.

  9/30/10 → 9/29/13

  Project: Research project

  • Toxoplasma gondii 100%
  • parasites 83%
  • proteomics 61%
  • pathogens 61%
  • Plasmodium 60%

• A trial of Positively Smoke Free group therapy for HIV-infected smokers

  Shuter, J. & Rose, S. A.

  8/1/13 → 7/31/19

  Project: Research project

  • Smoke 100%
  • HIV 63%
  • Smokers 55%
  • Costs and Cost Analysis 24%
  • Tobacco Use Cessation 18%

• A trial of Positively Smoke Free group therapy for HIV-infected smokers

  Shuter, J.

  NATIONAL INSTITUTE ON DRUG ABUSE

  8/1/13 → 7/31/19

  Project: Research project

  • Smoke 100%
  • Group Psychotherapy 96%
  • Smokers 84%
  • HIV 70%
  • Costs and Cost Analysis 27%

• A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Interventi

  Shuter, J. & Rose, S. A.

  5/15/09 → 4/30/12

  Project: Research project

  • HIV 100%
  • Smoking Cessation 81%
  • Comorbidity 37%
  • Tobacco Use 33%
  • Smokers 27%

• A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Interventi

  Shuter, J.

  NATIONAL INSTITUTE ON DRUG ABUSE

  5/15/09 → 4/30/12

  Project: Research project

  • Smoking Cessation 100%
  • HIV 80%
  • Comorbidity 30%
  • Tobacco Use 27%
  • Smokers 21%

• A Tumor Specific Therapy Approach for Small Cell Lung Cancer

  Zou, Y. & Rose, S. A.

  7/1/06 → 6/30/10

  Project: Research project

  • Small Cell Lung Carcinoma 100%
  • Neoplasms 36%
  • Genes 27%
  • Therapeutics 16%
  • human TERT protein 15%

• A Tumor Specific Therapy Approach for Small Cell Lung Cancer

  Zou, Y.

  National Cancer Institute

  7/1/06 → 6/30/10

  Project: Research project

  • Small Cell Lung Carcinoma 100%
  • Neoplasms 31%
  • Genes 25%
  • Therapeutics 15%
  • human TERT protein 14%